Background. Liver cirrhosis has been associated with decreased absolute CD4 cell counts but preserved CD4 cell percentage in human immunodeficiency virus (HIV)-negative persons. We evaluated factors associated with discordance between the absolute CD4 cell count and the CD4 cell percentage in a cohort of patients coinfected with HIV and hepatitis C virus (HCV).
been implicated as a possible cause of discordance between absolute CD4 cell counts and the CD4 cell percentage, making clinical interpretation of these values difficult [10] . A cross-sectional analysis of 60 HIV-negative patients with underlying liver cirrhosis found that 65% had evidence of low absolute CD4 cell count, although the CD4 cell percentage remained normal in 95% of patients with a low absolute CD4 cell count [10] . Hepatitis C virus (HCV)-related liver disease may therefore play a role in the development of discordant values between absolute CD4 cell count and CD4 cell percentage. Furthermore, HCV infection itself has been shown to affect CD4 lymphocyte counts before and after antiretroviral therapy (ART), raising the possibility that discordance may occur in coinfected individuals, even in the absence of advanced liver disease [11] .
The aim of this study was to evaluate factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in a cohort of HIV/HCV-coinfected patients. We focused on the roles of fibrosis, markers of end-stage liver disease (ESLD), HCV viremia, and HCV replication in absolute CD4 cell count and CD4 cell percentage discordance.
MATERIALS AND METHODS

Setting and Subjects
The Canadian HIV/HCV Coinfection Cohort is a prospective study involving 16 centers across Canada that, since 2003, has enrolled adults (age, >16 years) with documented HIV infection and serologic evidence of HCV exposure on the basis of antibody positivity, as previously described [12] . After informed consent is provided, participants undergo an initial evaluation and then attend follow-up visits approximately every 6 months. Participants complete questionnaires on demographic and social factors, injection drug use (IDU), alcohol use (quantity and frequency), and clinical parameters and provide blood for biochemical, serologic, virologic, and immunologic studies at each visit. Use of ART by participants is also recorded. The institutional review boards at each site approved the cohort study.
Definitions of Absolute CD4 Cell Count and CD4 Cell Percentage Discordance
The relationship between absolute CD4 cell count and CD4 cell percentage was extrapolated from prior population-based studies evaluating correlation between absolute CD4 cell count and CD4 cell percentage in HIV-infected patients [4, 13, 14] . Strata of concordant absolute CD4 cell counts and CD4 cell percentages were constructed empirically by plotting absolute CD4 cell counts expected for a given CD4 cell percentages on the basis of prior clinically defined thresholds [14] . In this manner, an absolute CD4 cell count of 100 cells/mm 3 corresponds to a CD4 cell percentage of <7%, an absolute CD4 cell count of 200-299 cells/mm 3 corresponds to a CD4 cell percentage of 14%-21%, and a CD4 cell count of 500 cells/ mm 3 corresponds to a CD4 cell percentage of >35%
( Figure 1 ). Strata in which the absolute CD4 cell count and CD4 cell percentage did not correspond to the expected pair relationship were classified as discordant. Strata in which the CD4 cell percentage was below that of the expected value for a corresponding absolute CD4 cell count were classified as low discordant, and strata in which the CD4 cell percentage was higher than that expected for a corresponding absolute CD4 cell count were classified as high discordant. If the CD4 cell percentage was >14 percentage points above or below the expected CD4 cell percentage for a corresponding CD4, then the stratum was classified as very high or very low discordant ( Figure 1 ). Data from the baseline visits of cohort participants were used for absolute CD4 cell count and CD4 cell percentage evaluation.
Measure of Liver Disease
A noninvasive marker of liver fibrosis, the aspartate transaminase (AST) to platelet ratio index (APRI), calculated as 100 × [(AST level)/(upper limit of normal)]/platelet count, where the upper limit normal is defined as an AST level of 35 U/mL, was determined at baseline for all patients [15] . An APRI of >1.5 has been validated as a marker of significant liver fibrosis in coinfected patients [16] . Baseline APRIs were divided into 3 categories: APRI < 0.5, which is indicative of the absence of fibrosis and was used as the reference category; 0.5 ≤ APRI ≤ 1.5; and APRI > 1.5. The presence of any one of the following was considered to be an ESLD diagnosis: Figure 1 . Definition of discordance between absolute CD4 cell count and CD4 percentage.
cirrhosis, ascites, esophageal varices, spontaneous bacterial peritonitis, portal hypertension, encephalopathy, or hepatocellular carcinoma. HCV viremia was confirmed if HCV RNA was detected by the Roche Cobas Amplicor assay (lower limit of detection, 60 IU/mL). Spontaneous clearance was defined as the absence of HCV RNA without ever having received HCV therapy. Successful HCV therapy was defined as the absence of HCV RNA ≥6 months after completing HCV treatment.
Covariates
The following variables were investigated for their association with discordance: age; sex; time since HIV diagnosis, using the date of first positive HIV test; duration of HCV infection, determined on the basis of the date of HCV seroconversion, if known, or the year of first IDU or blood product exposure as a proxy for HCV infection [17] ; current receipt of ART; current IDU; and alcohol consumption.
Statistical Analysis
We classified all patients initially into the following 3 groups on the basis of the size of the difference between CD4 cell count and CD4 cell percentage: very low discordance/low discordance; concordance; high discordance/very high discordance. The factors associated with very low/low discordance and high/very high discordance were analyzed using logistic regression models. Two separate multivariate models, prior history of ESLD and APRI >1.5, were created to account for collinearity between chosen measures of liver disease. In both cases, final models were adjusted for age, sex, time since HIV diagnosis, and markers of HIV disease stage, as well as factors found to be significant in univariate analyses, and were compared to values for the concordant group. Associations between spontaneous clearance and prior successful HCV therapy and discordance were also analyzed in the logistic regression models. Finally, factors associated with high and very high discordance as separate strata were analyzed using multivariate models in which the comparator group consisted of those with concordant/low/very low values. The data were analyzed using SAS software, version 9.1 (SAS Institute, Cary, NC), and all reported P values were 2-sided.
RESULTS
A total of 908 participants were evaluated. Table 1 .
Factors Associated With Discordant Absolute CD4 Cell Count and CD4 Cell Percentage
Adjusted multivariate analyses of factors associated with very low/low discordance and high/very high discordance for models of prior history of ESLD or APRI >1.5 are presented in Tables 2 and 3 . Low/very low discordance was only associated with higher total lymphocyte count in both models including either history of ESLD (adjusted odds ratio [aOR], 5.38; 95% confidence interval [CI], 3.39-8.52) or an APRI >1.5 (aOR 5.41; 95% CI, 3.42-8.58), compared with an APRI <0.5. In contrast, a preserved total lymphocyte count was inversely associated with presence of high/very high discordance in both models.
Markers of significant liver disease were associated only with presence of high/very discordance. History of prior ESLD was strongly associated with high/very high discordance (aOR, 2.76; 95% CI, 1.14-6.67), as was an APRI >1.5 (aOR, 2.48; 95% CI, 1.19-5.15), compared with an APRI <0.5 (Tables 2 and 3) .
When presence of high or very high discordance were evaluated individually in the multivariate models (Tables 4 and 5) , association with significant liver disease was seen only with very high discordance (aOR of 6.54 [95% CI 2.27-18.67] for history of ESLD and aOR of 4.69 [95% CI, 1.64-13.65] for an APRI >1.5, compared with an APRI <0.5).
Presence of high/very high discordance was inversely associated with duration of HIV infection and history of prior AIDS-defining illness but not with other markers of advanced HIV infection, such as nadir CD4 cell count, in both models. In other models, the effects of suppressed HIV RNA load at baseline (HIV RNA load, <50 copies/mL) was examined and was not found to be associated with discordance, nor did its inclusion in the multivariate model alter the main results (data not shown). Finally, neither ethnicity nor mode of acquisition were significantly associated with discordance.
The effect of the presence of replicating HCV on high or very high discordance was evaluated (Tables 4 and 5) . When compared to those with ongoing HCV viremia, those with spontaneous clearance of HCV were less likely to have very high discordance in both models (aOR of 0.08 [95% CI, .008-.87] in the ESLD model and aOR of 0.09 [95% CI, .009-.99] in the APRI model). The potential effect of HCV therapy was also evaluated among 84 individuals who had complete HCV RNA data available. None of those who obtained a sustained virologic response (n = 27) exhibited high discordance, compared with 10 (9%) of those who remained HCV RNA positive. However, those who did not clear did not have a statistically significant higher odds of discordance (aOR, 5.09; 95% CI .27-95.99); given the small numbers of patients and large number of covariates for adjustment, the CI around this estimate was very wide.
DISCUSSION
Discordance between values of absolute CD4 cell count and CD4 cell percentage was common in our cohort of coinfected patients, with 31% of participants demonstrating the presence of high/very discordant values. Discordance between absolute CD4 cell count and CD4 cell percentage among coinfected individuals had been observed in other cohorts. In 1955 HIVinfected patients from Johns Hopkins, coinfected patients (n = 873) had a lower absolute CD4 cell count but higher median CD4 cell percentage (19% vs 16%; P = .01) than HIV monoinfected patients [18] . Similar levels of discordance were observed in the HOMER cohort from British Columbia, Canada, where the baseline CD4 cell percentage in coinfected patients was 19%, compared with 16% for monoinfected patients (P < .001), despite similar median absolute CD4 cell count [19] . To our knowledge, this is the first study to examine the correlates of discordance in a large number of coinfected patients. The presence of low or very low discordance was associated with higher total overall lymphocyte count but not with markers of either HIV infection or liver disease. In contrast, the presence of high or very high discordance was strongly associated with markers of advanced liver disease. History of ESLD was strongly correlated with high/very high discordance, and this association was more pronounced when individuals with very high discordance were assessed as a separate category. Similarly, the APRI score, which has previously been validated as a means of predicting fibrosis within our cohort [16] , was associated with high/very high discordance, again predominantly with very high discordance. The association between progressive liver disease and discordance observed here supports the findings of other studies in HCV monoinfection and the hypothesis that the development of portal hypertension and splenomegaly may lead to a degree of sequestration of lymphocytes and other cell lines [10] . In a cross-sectional analysis of 60 patients with cirrhosis, the finding of abnormal absolute CD4 cell count with preserved CD4 cell percentage was associated with esophageal varices, splenomegaly, and laboratory markers of advanced disease, including thrombocytopenia and overall leukopenia [10] . Similarly, low total lymphocyte count and hemoglobin values suggestive of splenic sequestration in our cohort were associated with high and very high discordance when evaluated as separate categories. Recently, an association between discordance and stage of liver disease was seen in a study of injection drug users undergoing transient elastography. Among HIV-infected participants, the odds of higher CD4 cell percentage relative to absolute CD4 cell count was increased in those with higher liver stiffness (OR, 1.05 for each kPA increase in stiffness; P = .013) [20] . In our study, spontaneous clearance of HCV RNA was protective for the presence of very high discordance, in keeping with the hypothesis that progressive liver disease is associated with the development of discordance. However, given that the absence of HCV RNA remained independently protective for high discordance after accounting for ESLD or stage of fibrosis, it is possible that active HCV replication itself may contribute to discordance. Successful HCV treatment appeared to possibly be protective for high and very high discordance, as none of the patients who had undergone therapy and achieved sustained virologic response exhibited discordance, compared with 9% of those who remained HCV RNA positive. However, in multivariate models there was no association observed between sustained virologic response and discordance, possibly because of small numbers of patients having undergone therapy. While HCV therapy has been associated with improvement in fibrosis and inflammation and with improved hepatic outcomes [21, 22] , posttreatment regression of fibrosis may be slow, and long periods of follow-up may be required to document improvement in fibrosis scores [21] and, consequently, a return to CD4 cell concordance.
In the models for both history of ESLD and APRI score, markers of more advanced HIV infection (eg, longer duration of HIV and history of prior AIDS-defining illnesses) were inversely associated with discordance, which at first seems counterintuitive. A possible explanation is that the profound CD4 cell count depletion seen in the setting of advanced HIV disease may result in both absolute CD4 cell counts and CD4 cell percentages being concordantly very low and, as such, not sensitive to the effects of splenic sequestration seen with concomitant advanced liver disease.
The clinical significance of absolute CD4 cell count and CD4 cell percentage discordance is less clear. Coinfected patients may have blunted immune restoration after initiation of ART [23] . A meta-analysis of 6216 patients from 8 studies found that coinfected patients had lower absolute CD4 cell count increases after at least 1 year of ART, compared with monoinfected patients [23] , but the meta-analysis did not directly assess the degree of liver disease and its potential blunting of immune restoration [19, 24] . When changes in CD4 cell percentage have been evaluated, the response after ART has been variable [18, 19] . In an analysis of our coinfected cohort, recovery of the absolute CD4 cell count after ART initiation among individuals with chronic replicating HCV RNA was on average 7 times slower than recovery for those with spontaneous clearance of HCV RNA, suggesting that HCV replication acts to impair the restoration of absolute CD4 cell count [11] .
Despite lower values due to liver disease, absolute CD4 cell counts retained predictive value for AIDS-defining events, compared with CD4 cell percentage, in an analysis of the Italian ICoNA cohort [25] . [25] . Initiating therapy at a lower CD4 cell count has been associated with increased risk of certain toxicities related to ART, including neuropathies and renal impairment [26] , and it is unclear whether these findings would differ in those with discordant CD4 cell counts due to liver disease. In addition, although absolute CD4 cell count remains predictive for AIDS-defining events [25] , uncertainty regarding need for prophylaxis for opportunistic infections and timing of initiation of ART among those with discordance persists. Our findings do suggest, however, that the presence of high CD4 cell discordance may serve as marker of significant liver disease and thus may have clinical utility for identifying patients for whom further liver disease staging using noninvasive methods or liver biopsy is indicated.
Our study has some limitations. The overall classification of the relationship between CD4 cell count and CD4 cell percentage we used was empirically defined, and further validation of this classification may be necessary. In addition, the classification strata are derived from common North American and European HIV-infected population norms, and these relationships may be different in other geographic/ethnic populations, which may limit the generalizability of these results [13, 14, 27] . We lacked sufficient numbers of successfully treated coinfected participants with long enough follow-up periods to be able to fully evaluate the effect of HCV therapy on regression of fibrosis and improvements in absolute CD4 cell count and CD4 cell percentage discordance. Finally, we used a surrogate marker of liver fibrosis, the APRI. While liver biopsy is considered to be the gold standard for measuring fibrosis, it is not without its limitations. Liver biopsies are invasive and difficult to repeat, often causing studies that use this measure of fibrosis to be limited in sample size and by patient selection bias. In addition, results may be affected by tissue sampling and interpretation error [28, 29] . However, the consistency in results between the models using APRI and ESLD is evidence that the APRI is as an accurate marker of liver disease stage in this setting.
In summary, approximately 30% of HIV/HCV-coinfected patients demonstrated a high/very high discordant relationship between absolute CD4 cell count and CD4 cell percentage. High discordance was associated with the presence of progressive liver disease. Further study is required to determine whether regression of inflammation and fibrosis following successful HCV eradication may lead to a return to a more concordant absolute CD4 cell count and CD4 cell percentage relationship and to determine whether CD4 cell discordance is associated with adverse clinical outcomes.
Notes
